Ignite Creation Date:
2025-12-25 @ 1:42 AM
Ignite Modification Date:
2026-05-22 @ 4:23 PM
Study NCT ID:
NCT05738694
Status:
RECRUITING
Last Update Posted:
2023-05-09
First Post:
2023-01-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
Sponsor:
ZHOU FANGJIAN
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2021-FXY-518
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |